Download ISTH 2009 Sales Manual (PDF 3.32 MB)

ISTH 2009 Rules and Regulations
ISTH Abstract Embargo Policy
Accepted abstracts are published on a CD-ROM at the Congress (the
“Abstract CD-ROM”). Information contained in abstracts may not be
released until midnight (Eastern Standard Time, North America) July 12,
the opening day of the Congress.
Academic institutions, private organizations and companies with
products whose value may be influenced by information contained in an
abstract, may issue a press release to coincide with the availability of an
abstract on the CD-ROM. However, ISTH requires that information going
beyond that contained in the abstract, such as discussion of the abstract,
presentation of data or other details that will be presented at the
Congress, is under embargo as outlined above. Violation of the
embargo may result in the abstract being withdrawn from the Congress
and/or other measures deemed appropriate.
It is not considered a violation of this policy if the information contained
in the abstract is presented or has been accepted for presentation at
another meeting (as noted during abstract submission), or if the abstract
is published in a peer reviewed journal after the abstract submission
deadline.
It is the responsibility of the submitting author to inform interested parties
about this policy.
Food and Drug Administration (FDA)
Approval and Off-Label Indications
The mention (directly or indirectly) of pharmaceutical products not
approved by the FDA for use within the United States is strictly
prohibited. Symposia, conferences, handouts or literature of any kind
that mention such products directly or indirectly are, likewise, prohibited
from display in the exhibit space or in spaces contracted by the ISTH.
An exhibiting organization may disseminate from its exhibit space peerreviewed
journal articles about off-label indications of its product(s),
provided the company commits itself to file a supplemental application
based on appropriate research, to establish the safety and effectiveness
of the unapproved use.
16
XXII ND CONGRESS OF THE INTERNATIONAL SOCIETY ON THROMBOSIS AND HAEMOSTASIS